{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:38:24Z","timestamp":1759333104573,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T00:00:00Z","timestamp":1529452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12886-018-0818-y","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T09:02:05Z","timestamp":1529485325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Vitreous opacities after intravitreal triamcinolone injection- a case report"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5687-6384","authenticated-orcid":false,"given":"Dhanashree","family":"Ratra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vineet","family":"Ratra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haard","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,20]]},"reference":[{"issue":"4","key":"818_CR1","first-page":"546","volume":"6","author":"XL Zhang","year":"2013","unstructured":"Zhang XL, Chen J, Zhang RJ, Wang WJ, Zhou Q, Qin XY. Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema: a meta-analysis. Int J Ophthalmol. 2013;6(4):546\u201352.","journal-title":"Int J Ophthalmol"},{"issue":"4","key":"818_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ophtha.2010.12.033","volume":"118","author":"MJ Elman","year":"2011","unstructured":"Elman MJ, Bressler NM, Qin H, Beck RW, Ferris FL 3rd, Friedman SM, Glassman AR, Scott IU, Stockdale CR, Sun JK, Diabetic Retinopathy Clinical Research Network. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2011;118(4):609\u201314.","journal-title":"Ophthalmology"},{"issue":"9","key":"818_CR3","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.ophtha.2008.06.015","volume":"115","author":"Diabetic Retinopathy Clinical Research Network","year":"2008","unstructured":"Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal\/grid photocoagulation for diabetic macular edema. Ophthalmology. 2008;115(9):1447\u20139. 1449.e1\u201310","journal-title":"Ophthalmology"},{"key":"818_CR4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1097\/00006982-200410000-00002","volume":"24","author":"RD Jager","year":"2004","unstructured":"Jager RD, Aiello LP, Patel SP, Cunningham ET Jr. Risks of intravitreous injection: a comprehensive review. Retina. 2004;24:676\u201398.","journal-title":"Retina"},{"key":"818_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4103\/0301-4738.15291","volume":"53","author":"V Vedantham","year":"2005","unstructured":"Vedantham V, Kolluru C, Ramasamy K. Persistent depot of triamcinolone acetonide after a single intravitreal injection. Indian J Ophthalmol. 2005;53:65\u20136.","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"818_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/112067210901900214","volume":"19","author":"H Hosseini","year":"2009","unstructured":"Hosseini H, Anvari-Ardakani HR, Karanjam MA, Farvardin M, Nowroozizadeh S. Ultrasonographic pictures of intravitreal triamcinolone acetonide. Eur J Ophthalmol. 2009;19(2):263\u20137.","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"818_CR7","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/00006982-200310000-00014","volume":"23","author":"ML Nelson","year":"2003","unstructured":"Nelson ML, Tennant MT, Sivalingam A, Regillo CD, Belmont JB, Martidis A. Infectious and presumed non-infectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina. 2003;23(5):686\u201391.","journal-title":"Retina"},{"issue":"3","key":"818_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ajo.2004.03.025","volume":"138","author":"AA Moshfeghi","year":"2004","unstructured":"Moshfeghi AA, Scott IU, Flynn HW Jr, Puliafito CA. Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema. Am J Ophthalmol. 2004;138(3):489\u201392.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"818_CR9","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1136\/bjo.87.8.972","volume":"87","author":"FKP Sutter","year":"2003","unstructured":"Sutter FKP, Gillies MC. Pseudo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol. 2003;87(8):972\u20134.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"818_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/0002-9394(86)90593-3","volume":"101","author":"T Hida","year":"1986","unstructured":"Hida T, Chandler D, Arena JE, Machemer R. Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol. 1986;101(2):190\u20135.","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"818_CR11","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1001\/archophthalmol.2009.233","volume":"127","author":"IU Scott","year":"2009","unstructured":"Scott IU, Ip MS, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Chan CK, Gonzalez VH, Singerman LJ, Tolentino M. SCORE study research group a randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 6. Arch Ophthalmol. 2009;127(9):1115\u201328.","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"818_CR12","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.ophtha.2010.01.052","volume":"117","author":"ME Kleinman","year":"2010","unstructured":"Kleinman ME, Westhouse SJ, Ambati J, Pearson PA, Halperin LS. Triamcinolone crystal size. Ophthalmology. 2010;117(8):1654.","journal-title":"Ophthalmology"},{"issue":"5","key":"818_CR13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00417-006-0436-x","volume":"245","author":"P Szurman","year":"2007","unstructured":"Szurman P, Kaczmarek R, Jaissle GB, Grisanti S, L\u00fcke M, Spitzer MS, Heide PE, Bartz-Schmidt KU. Influence of different purification techniques on triamcinolone yield and particle size spectrum. Graefes Arch Clin Exp Ophthalmol. 2007;245(5):689\u201396.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"818_CR14","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/IAE.0b013e31819e390a","volume":"29","author":"AA Moshfeghi","year":"2009","unstructured":"Moshfeghi AA, Nugent AK, Nomoto H, Sanislo SR, Kitchens JW, Moshfeghi DM. Triamcinolone acetonide preparations: impact of crystal size on in vitro behavior. Retina. 2009;29(5):689\u201398.","journal-title":"Retina"},{"issue":"10","key":"818_CR15","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1097\/IAE.0b013e318214d076","volume":"31","author":"MS Spitzer","year":"2011","unstructured":"Spitzer MS, Mlynczak T, Schultheiss M, Rinker K, Yoeruek E, Petermeier K, Januschowski K, Szurman P. Preservative-free triamcinolone acetonide injectable suspension versus \u201ctraditional\u201d triamcinolone preparations: impact of aggregate size on retinal biocompatibility. Retina. 2011;31(10):2050\u20137.","journal-title":"Retina"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-018-0818-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-018-0818-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-018-0818-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T19:04:52Z","timestamp":1560971092000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-018-0818-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,20]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["818"],"URL":"https:\/\/doi.org\/10.1186\/s12886-018-0818-y","relation":{},"ISSN":["1471-2415"],"issn-type":[{"type":"electronic","value":"1471-2415"}],"subject":[],"published":{"date-parts":[[2018,6,20]]},"assertion":[{"value":"2 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The institutional review board of Medical Research Foundation approved the study and written informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from every patient for publication of this case report and any accompanying images. All copies of the written consent are available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DR has received research grant from Novartis Healthcare for another study. None of the other authors have any competing interests to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"145"}}